Physician profile
David M Broderick
NPI 1770522203
$553.62
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.93 · 2020: $32.01 · 2021: $136 · 2022: $161 · 2023: $96.72 · 2024: $79.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $142.21 | 2021-2024 | Tirosint, Licart, Tirosint |
| Orthofix Medical, INC. | $121.88 | 2022-2024 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $95.62 | 2019-2021 | |
| Smith+Nephew, INC. | $56.30 | 2021-2022 | |
| Next Science LLC | $26.63 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.44 | 2023 | Exparel, Iovera, Zilretta |
| Depuy Synthes Sales INC. | $18.44 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.03 | 2020 | |
| Anika Therapeutics, INC. | $15.47 | 2021 | |
| Paragon 28, INC. | $14.01 | 2021 | |
| Amgen INC. | $13.44 | 2022 | |
| Zimvie INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Broderick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.